ArticleJournal of nanobiotechnology2025

Reengineering glycyrrhetinic acid into a therapeutic oligomer for targeted tumor therapy with cardioprotection.

Zixin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.